ARGENT BIOPHARMA LIMITED - Announcements

Market Cap $13.58M Add to my watchlist

Healthcare

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

Announcements

Filter Results

All Price Sensitive Only

RGT	Pre-Reinstatement Disclosure		27/09/12	83.61KB	Share
RGT	ASX Reinstatement Circular		26/09/12	164.13KB	Share
RGT	Reinstatement to Official Quotation - 28 September 2012	PRICE SENSITIVE	26/09/12	77.01KB	Share
RGT	Resignation of Director and Appendix 3Z		25/09/12	238.71KB	Share
RGT	Financial Report for the year ended 30 June 2012		24/09/12	1.2MB	Share
RGT	Update on Reinstatement of Official Quotation		24/09/12	196.03KB	Share
RGT	Form 603 - Initial Substantial Shareholder Notice		19/09/12	33.05KB	Share
RGT	Appendix 3Y - Change of Directors Interest Notice		18/09/12	118.25KB	Share
RGT	Form 604 - Change of Interests of Substantial Holder		17/09/12	186.68KB	Share
RGT	Form 605 - Ceasing to be a Substantial Holder Notice x 4		17/09/12	524.32KB	Share
RGT	Appendix 3Y - Change of Directors Interest Notice x 2		17/09/12	137.42KB	Share
RGT	Appendix 3x and Appendix 3z		14/09/12	124.72KB	Share
RGT	Completion of the Acquisition - Appendix 3B		14/09/12	292KB	Share
RGT	Completion of Capital Raising and Issue of Shares		12/09/12	198.25KB	Share
RGT	Supplementary Prospectus		06/09/12	42.66KB	Share

RGTPre-Reinstatement Disclosure
27/09/12		83.61KB	Share
RGTASX Reinstatement Circular
26/09/12		164.13KB	Share
RGTReinstatement to Official Quotation - 28 September 2012
26/09/12	PRICE SENSITIVE	77.01KB	Share
RGTResignation of Director and Appendix 3Z
25/09/12		238.71KB	Share
RGTFinancial Report for the year ended 30 June 2012
24/09/12		1.2MB	Share
RGTUpdate on Reinstatement of Official Quotation
24/09/12		196.03KB	Share
RGTForm 603 - Initial Substantial Shareholder Notice
19/09/12		33.05KB	Share
RGTAppendix 3Y - Change of Directors Interest Notice
18/09/12		118.25KB	Share
RGTForm 604 - Change of Interests of Substantial Holder
17/09/12		186.68KB	Share
RGTForm 605 - Ceasing to be a Substantial Holder Notice x 4
17/09/12		524.32KB	Share
RGTAppendix 3Y - Change of Directors Interest Notice x 2
17/09/12		137.42KB	Share
RGTAppendix 3x and Appendix 3z
14/09/12		124.72KB	Share
RGTCompletion of the Acquisition - Appendix 3B
14/09/12		292KB	Share
RGTCompletion of Capital Raising and Issue of Shares
12/09/12		198.25KB	Share
RGTSupplementary Prospectus
06/09/12		42.66KB	Share

REFRESH

First 6 7 8 9 10

(20min delay)
Last 30.0¢		Change 0.000(0.00%)		Mkt cap ! $13.58M

Open	High	Low	Value	Volume
30.0¢	31.0¢	30.0¢	$2.567K	8.41K

Buyers (Bids)

No.	Vol.	Price($)
2	47481	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	8026	2

View Market Depth

No.	Vol.	Price($)
2	47481	0.300
1	17426	0.275
1	15000	0.250
1	40820	0.245
1	18524	0.240

Price($)	Vol.	No.
0.310	8026	2
0.315	2876	1
0.320	2479	3
0.325	5304	1
0.330	2316	1

Last trade - 15.53pm 21/06/2024 (20 minute delay)


Last 30.0¢		Change 0.000 ( 1.64 %)
Open	High	Low	Volume
30.0¢	30.0¢	30.0¢	1601
Last updated 15.13pm 21/06/2024 ?

RGT (ASX) Chart

ARGENT BIOPHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories